Advertisement
Advertisement

ALT

ALT logo

Altimmune, Inc. Common Stock

3.09
USD
Sponsored
+0.05
+1.64%
May 08, 15:58 UTC -4
Closed
exchange

Pre-Market

3.08

-0.01
-0.32%

Altimmune, Inc. Common Stock Profile

About

Altimmune, Inc. is a clinical-stage immunotherapeutics company. It focused on the development of products to stimulate robust and durable immune responses for the prevention and treatment of disease. The company's proprietary platform technologies consist of RespirVec and Densigen. Altimmune Inc., formerly known as Pharmathene Inc., is based in Gaithersburg, United States.

Info & Links

CEO

Jerome Durso

Headquarters

910 CLOPPER ROAD, SUITE 201S
GAITHERSBURG, MD 20878, UNITED STATES

Industry

Medical Drugs

Sector

Medical

Website

https://altimmune.com

Auditor

Ernst & Young LLP

Share holders

193

Employees

57

Altimmune, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

598.61M

Enterprise Value

589.10M

Enterprise Value/EBITDA(ttm)

-6.12

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

10.73K

Price to Book(mrq)

1.70

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-214860.98%

Profit Margin(ttm)

-329980.78%

Return on Equity(ttm)

-49.35%

Return on Invested Capital(ttm)

-46.43%

Return on Assets(ttm)

-41.65%

Income Statement

Revenue(ttm)

41.00K

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

41.00K

EBITDA(ttm)3

-96.24M

Net Income Available to Common(ttm)

-88.09M

Diluted EPS(ttm)

-1.01

Share Statistics

Beta (5Y Monthly)

0.34

52-Week Change

-44.72%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

130.07M

Dividend Yield

0.00%

Float4

128.02M

% Held by Insiders

1.60%

% Held by Institutions

78.05%

Balance Sheet

Total Cash(mrq)

273.50M

Total Cash Per Share(mrq)

2.10

Total Debt(mrq)

34.29M

Total Debt/Equity(mrq)

15.25%

Current Ratio(mrq)

18.55%

Quick Ratio(mrq)

18.55%

Book Value Per Share(mrq)

2.03

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.77

Free Cash Flow(ytd)

-67.55M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement